Zur Hauptnavigation wechseln
Zur Suche wechseln
Zum Hauptinhalt wechseln
Technische Universität München Home
Hilfe und FAQ
English
Deutsch
Home
Personen
Einrichtungen
Projekte
Publikationen
Ausstattungen/Einrichtungen
Auszeichnungen
Aktivitäten
Presseberichte
Nach Expertise, Namen oder Zugehörigkeit suchen
Gabapentin for chronic neuropathic pain in adults
Philip J. Wiffen
, Sheena Derry
, Rae F. Bell
, Andrew S.C. Rice
,
Thomas Rudolf Tölle
, Tudor Phillips
, R. Andrew Moore
Ehemalige Einrichtungen Medicine and Health
University of Oxford Medical Sciences Division
Haukeland University Hospital
Imperial College London
Publikation
:
Beitrag in Fachzeitschrift
›
Übersichtsartikel
›
Begutachtung
235
Zitate (Scopus)
Übersicht
Fingerprint
Fingerprint
Untersuchen Sie die Forschungsthemen von „Gabapentin for chronic neuropathic pain in adults“. Zusammen bilden sie einen einzigartigen Fingerprint.
sortieren
Gewicht:
Alphabetisch
Keyphrases
Gabapentin
100%
Chronic Neuropathic Pain
100%
Pain Relief
66%
Placebo
50%
Risk Ratio
44%
Patient Global Impression of Change
33%
Adverse Events
22%
Neuropathic Pain
22%
Pain Patients
22%
Pain Level
16%
Postherpetic Neuralgia
16%
Pooled Analysis
11%
Painful Diabetic Neuropathy
11%
Route of Administration
5%
Quality of Life
5%
Selection Criteria
5%
Beneficial Effects
5%
MEDLINE
5%
January 2017
5%
Randomized Controlled Trial
5%
High Risk
5%
Search Methods
5%
Embase
5%
Treatment Outcome
5%
Adverse Effects
5%
Pain Conditions
5%
Serious Adverse Events
5%
Active Treatment
5%
Potential Bias
5%
Pain Intensity
5%
Clinical Trial Registry
5%
Nerve Damage
5%
Randomized Double-blind Trial
5%
Beneficial Outcomes
5%
Life Functioning
5%
Risk of Bias
5%
Review Update
5%
Dizziness
5%
Pain Assessment
5%
Quality of Work
5%
Gait Disturbance
5%
Review Authors
5%
Number-needed-to-treat
5%
Somnolence
5%
Sleep Interference
5%
Study Withdrawal
5%
Analgesic Efficacy
5%
Summary of Findings Table
5%
Peripheral Edema
5%
Trial Quality
5%
Peripheral Diabetic Neuropathy
5%
Intensity Reduction
5%
Oral Gabapentin
5%
Life Work
5%
Extracted Data
5%
Dichotomous Data
5%
Medicine and Dentistry
Neuropathic Pain
100%
Gabapentin
100%
Analgesia
63%
Placebo
47%
Adverse Event
26%
Diabetic Neuropathy
15%
Postherpetic Neuralgia
15%
Pooled Analysis
10%
Quality of Life
5%
Clinical Trial
5%
Randomized Controlled Trial
5%
Peripheral Edema
5%
Nerve Injury
5%
Dizziness
5%
Numbers Needed to Treat
5%
Somnolence
5%
Analgesic Efficacy
5%
Pain Assessment
5%
Adverse Effect
5%
Primary Outcome
5%
Oral
5%
Active Treatment
5%
Pharmacology, Toxicology and Pharmaceutical Science
Gabapentin
100%
Neuropathic Pain
100%
Placebo
47%
Adverse Event
26%
Diabetic Neuropathy
15%
Postherpetic Neuralgia
15%
Randomized Controlled Trial
5%
Clinical Trial
5%
Route of Administration
5%
Number Needed to Treat
5%
Analgesic Agent
5%
Dizziness
5%
Nerve Injury
5%
Somnolence
5%
Peripheral Edema
5%
Neuroscience
Gabapentin
100%
Neuropathic Pain
100%
Placebo
47%
Postherpetic Neuralgia
15%
Diabetic Neuropathy
15%
Randomized Controlled Trial
5%
Adverse Effect
5%
Crossover Study
5%
Somnolence
5%
Nerve Injury
5%
Quality of Life
5%